[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Klinik für Kardiologie, Pneumologie und Angiologie\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":120},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,82,100],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100194339","multi-modal-cardiac-imaging-prior-transcatheter-aortic-valve-implantation-100194339",false,"NCT01805739","Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation","Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation (TAVI)","Inclusion Criteria:\n\n* aortic valve stenosis\n* screened for TAVI\n* written informed consent\n\nExclusion Criteria:\n\n* unconsciousness, not able to consent","ALL","18 Years",{"count":19,"type":20},5000,"ESTIMATED","12 Months","OBSERVATIONAL","Transcatheter aortic valve implantation (TAVI) is an emerging alternative therapy for aortic stenosis for patients ineligible for open heart surgery or at high risk for perioperative complications. Pre-procedural imaging of the aortic root is essential for selection of the correct valve prosthesis and to minimize complications as prosthesis mismatch, possibly subsequent embolization, coronary obstruction, annulus rupture or severe aortic regurgitation.\n\nThe aim of the study is to compare the different imaging modalities for aortic root measurements.\n\nAortic root imaging will be performed prior to TAVI-procedure. The contrast injection will be performed either into the aorta or into the left ventricle. The datasets will be assessed by blinded-independent observers in a multi-planar reconstruction view.\n\nThe study will be performed retrospectively (2009-2012) and prospectively starting 2013.",[25],"Aortic Valve Stenosis",[27,28,29,30,31,32],"transcatheter aortic valve implantation","CT","MRI","angiography","echocardiography","rotational C-arm CT","RECRUITING","2020-10-28",{"date":36,"type":37},"2020-10-30","ACTUAL",{"date":39,"type":4},"2013-01",{"date":41,"type":20},"2030-12",{"name":43,"class":44},"Klinik für Kardiologie, Pneumologie und Angiologie","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":56,"studyType":22,"phases":4,"briefSummary":57,"conditions":58,"keywords":65,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":81,"locationsCount":45},"100313420","registry-of-device-implantation-100313420","NCT03360227","Registry of Device Implantation","Registry of Device Implantation in University Hospital Duesseldorf","Inclusion Criteria:\n\n1. pre-operative clinical history taking\n2. pre-operative functional investigations (cardiac echo, electrocardiograms)\n3. pre-operative laboratory data evaluation (kidney function, liver function, biomarkers, thyroid hormone, CBC)\n\nExclusion Criteria:\n\n１. no written informed consent","80 Years",{"count":55,"type":20},2000,"24 Months","The implantable device therapy for cardiac arrhythmias has been an established therapy, and one of the common standard procedures in cardiac clinical practice.\n\nPacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy have been developed since 1960s, and the technologies in this field are still progressively developing. Not only these \"traditional\" implantable devices, there are multiple new devices for cardiac diseases, such as implantable loop recorder, vagal nerve stimulator and barostimulator.\n\nThe aim of this registry is to demonstrate the efficacy and the safety of standard device implantation procedures and to evaluate\u002F identify specific factors, including clinical characteristics, laboratory data and procedural data, which predict the prognosis\u002Fcomplication of the patients. These identification will result in further improvement of patients' care.",[59,60,61,62,63,64],"Syncope","Bradycardia","Tachycardia","Sudden Cardiac Death","Ventricular Tachycardia","Ventricular Fibrillation",[66,67,68,69,70,71,72,73,74],"syncope","bradycardia","tachycardia","sudden cardiac death","implantable cardioverter-defibrillator","ventricular tachycardia","ventricular fibrillation","biomarker","thyroid hormone","2020-02-06",{"date":77,"type":37},"2020-02-07",{"date":79,"type":37},"2011-01",{"date":41,"type":20},{"name":43,"class":44},{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":89,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":91,"conditions":92,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":94,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":45},"100264956","percutaneous-transluminal-angioplasty-registry-100264956","NCT02728479","Percutaneous Transluminal Angioplasty Registry","PTA Registry - an Observational Study of Percutaneous Transluminal Angioplasty","Inclusion Criteria:\n\n* Patients undergoing PTA\n\nExclusion Criteria:\n\n* \\\u003C 18 years",{"count":90,"type":20},1000,"Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease.\n\nThe aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.",[93],"Percutaneous Transluminal Angioplasty",{"date":77,"type":37},{"date":96,"type":4},"2014-01",{"date":98,"type":20},"2030-01",{"name":43,"class":44},{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":107,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":109,"conditions":110,"keywords":112,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":116,"startDateStruct":117,"completionDateStruct":118,"leadSponsor":119,"locationsCount":45},"100211774","mitraclip-registry-100211774","NCT02033811","MitraClip® Registry","MitraClip® Registry - an Observational Study of Percutaneous Mitral Valve Repair Using the MitraClip® System","Inclusion Criteria:\n\n* severe mitral regurgitation\n* percutaneous mitral valve repair (PMVR) with the MitraClip® system\n\nExclusion Criteria:\n\n* \\\u003C 18 years\n* Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure",{"count":108,"type":20},200,"Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients.\n\nThe aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.",[111],"Mitral Regurgitation",[113,114,115],"mitral regurgitation","MitraClip system","percutaneous mitral valve repair",{"date":77,"type":37},{"date":96,"type":4},{"date":41,"type":20},{"name":43,"class":44},""]